Test Price
2,800 AED✅ Home Collection Available
TFAP2A Gene Branchiooculofacial Syndrome Genetic Test in UAE | 2800 AED
Executive Summary & Core Metrics
Core Metrics
Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Accredited Processing.
Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain Home Collection and VIP Mobile Phlebotomy.
Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation.
Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The TFAP2A gene test screens for mutations causing Branchiooculofacial syndrome (BOFS), a rare genetic disorder characterised by branchial, ocular, and facial anomalies. This NGS test offers comprehensive analysis of the entire coding region, enabling accurate diagnosis, carrier detection, and informed reproductive planning.
| Feature | Our Test (NGS) | Sanger Sequencing |
|---|---|---|
| Method | Next‑Generation Sequencing (Illumina) | Capillary Electrophoresis |
| Resolution | Full gene coverage (all exons, flanking intronic regions) | Limited to targeted amplicons |
| Turnaround Time | 3–4 Weeks | 2–4 Weeks (single region) |
| Clinical Sensitivity | ~99.9% – detects point mutations, small indels, CNVs | ~99% for the analysed fragment only |
| Price (AED) | 2800 | Varies (~2500-4000) |
| ISO Accreditation | ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139) | May vary |
Physician Insight & Safety Protocols
“As a medical geneticist, I understand that genetic testing for a rare condition like Branchiooculofacial syndrome can be emotionally demanding. This NGS analysis of the TFAP2A gene provides critical diagnostic information, but results must always be interpreted together with a complete clinical evaluation and family history. No single test replaces thorough medical assessment, and I strongly advise discussing findings with a clinical geneticist to ensure appropriate follow‑up and genetic counselling.” – Lina Osama Zaki Quteineh | Consultant Medical Genetics | DHA Registration ID: 9294403
Advisory & Safety Notice
Medical Notice:
Do not discontinue or alter any prescribed medication without prior consultation with your treating physician. This test is for diagnostic purposes only and does not replace clinical judgment.
Exclusion Criteria & Emergency Red Flags
Exclusion Criteria
- Exclusion Criteria: Known current acute infection at venipuncture site, inability to provide informed consent, severe coagulopathy unmanaged, or sample not collected as per cold‑chain protocol.
- ER Red Flags: If after home collection you experience fainting, persistent dizziness, uncontrolled bleeding, or signs of infection (redness, swelling, fever) – seek immediate medical attention.
- Pre‑Test Information: A genetic counselling session to draw a detailed family pedigree is mandatory. No dietary or medication restrictions, but provide a complete clinical history and any previous genetic reports.
Patient FAQ & Clinical Guidance
1. What sample is required for the TFAP2A gene test?
A blood sample or buccal swab is all that’s required for TFAP2A gene analysis; results in 3‑4 weeks. The sample is processed using NGS technology, and we accept either a whole blood EDTA tube, extracted DNA, or a single drop of blood on an FTA card.
2. Is fasting required before the blood draw?
No fasting is necessary; you can eat and drink as usual before giving a blood sample for this genetic test. Do not modify your regular diet unless instructed by your physician.
3. What does a positive result actually mean?
A positive result indicates a pathogenic mutation in the TFAP2A gene, confirming the diagnosis of Branchiooculofacial syndrome and guiding medical management and family screening. Your genetic counsellor will explain the inheritance pattern (autosomal dominant) and its implications for relatives.
UAE Regulatory & Data Privacy Adherence
Regulatory Compliance
This genetic test is fully compliant with UAE healthcare regulations. Data security is maintained in accordance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical safety and patient consent follow Federal Decree-Law No. 4 of 2016 on Medical Liability. The laboratory holds DHA Facility License Number 1143 and operates under the corporate brand DNA Labs UAE.
Clinical & Logistical Metadata
| Test Name | TFAP2A Gene Branchiooculofacial Syndrome Genetic Test |
| Price (AED) | 2800 |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Whole blood (EDTA tube), buccal swab, extracted DNA, or FTA card |
| Methodology Used | Next‑Generation Sequencing (NGS) – Illumina platform |
| ICD-10-CM Code | Q87.0 (Congenital malformation syndromes predominantly affecting facial appearance) |
| LOINC Code | 21624-1 (Gene mutations found [Identifier] in Blood or Tissue by Sequencing) |
| DHA Facility License & Laboratory Address | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DHA Facility License: 1143 | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians